Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
The aim of the study is to determine the Maximum Tolerated Dose (MTD) of afatinib in combination with 3-weekly trastuzumab in HER2 overexpressing cancer and to assess the efficacy of afatinib given at the MTD dosage, with 3-weekly trastuzumab in HER2 overexpressing metastatic breast cancer.
Inclusion criteria
- Breast Neoplasms ,Stomach Neoplasms